PROTAGONIST THERAPEUTICS INC (PTGX) Earnings History & Surprises
NASDAQ:PTGX • US74366E1029
91.41 USD
-3.42 (-3.61%)
At close: Mar 5, 2026
91.41 USD
0 (0%)
After Hours: 3/5/2026, 8:16:15 PM
Past quarterly earnings results for PROTAGONIST THERAPEUTICS INC (PTGX), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Release DateMay 4, 2026
PeriodQ4 / 2025
EPS Estimate-$0.54
Revenue Estimate9.105M
Last Reported
Release DateFeb 19, 2026
PeriodQ3 / 2025
EPS Reported-$0.62
EPS Surprise 4.88%
Revenue Surprise 27.04%
Beat Rate
81%
EPS and Revenuebeats vs estimates
Quarterly Earnings Results
EPS & Revenue History (USD)
Actual vs estimated values, surprises, q2q growth and acceleration numbers for recent quarters.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q3 2025 | -0.62 | -0.65 | 4.88% | -14.81% | 4.712M | 3.709M | 27.04% | 0.79% |
| Q2 2025 | -0.55 | -0.59 | 6.78% | -10.00% | 5.546M | 6.942M | -20.11% | 33.09% |
| Q1 2025 | -0.19 | -0.24 | 19.40% | -105.83% | 28.321M | 31.053M | -8.80% | -88.89% |
| Q4 2024 | 1.98 | 0.33 | 504.52% | 350.00% | 170.638M | 51.36M | 232.24% | 184.40% |
| Q3 2024 | -0.54 | -0.62 | 12.85% | 6.90% | 4.675M | 2.113M | 121.25% | - |
| Q2 2024 | -0.50 | -0.61 | 18.53% | 26.47% | 4.167M | 8.16M | -48.93% | - |
| Q1 2024 | 3.26 | 1.22 | 167.72% | 586.57% | 254.953M | 122.4M | 108.29% | - |
| Q4 2023 | 0.44 | -0.03 | 1,399.31% | 163.77% | 60M | 40.8M | 47.06% | - |
| Q3 2023 | -0.58 | -0.71 | 18.05% | 9.38% | 8.5M | -100.00% | - | |
| Q2 2023 | -0.68 | -0.66 | -2.99% | 19.05% | - | -100.00% | ||
| Q1 2023 | -0.67 | -0.74 | 9.61% | -55.81% | 2.04M | -100.00% | -100.00% | |
| Q4 2022 | -0.69 | -0.65 | -5.98% | 10.39% | 5.1M | -100.00% | -100.00% | |
| Q3 2022 | -0.64 | -0.89 | 27.71% | 8.57% | - | -100.00% | ||
| Q2 2022 | -0.84 | -0.95 | 11.13% | -21.74% | 860K | 390.997K | 119.95% | -62.11% |
| Q1 2022 | -0.43 | -0.64 | 32.91% | 20.37% | 25.72M | 17.391M | 47.89% | 315.51% |
| Q4 2021 | -0.77 | -0.80 | 3.53% | -60.42% | 8.62M | 5.173M | 66.63% | 52.57% |
| Q3 2021 | -0.70 | -0.68 | -2.43% | -233.33% | 10.29M | 1.778M | 478.74% | -21.51% |
| Q2 2021 | -0.69 | -0.56 | -23.64% | -13.11% | 2.27M | 5.275M | -56.97% | -63.50% |
| Q1 2021 | -0.54 | -0.58 | 6.79% | 25.00% | 6.19M | 1.53M | 304.58% | 69.59% |
| Q4 2020 | -0.48 | -0.49 | 1.55% | - | 5.65M | 3.188M | 77.23% | - |
| Q3 2020 | -0.21 | -0.62 | 66.39% | - | 13.11M | 2.193M | 497.81% | - |
| Q2 2020 | -0.61 | -0.61 | -0.51% | - | 6.22M | 2.584M | 140.71% | - |
| Q1 2020 | -0.72 | -0.71 | -2.01% | - | 3.65M | 1.51M | 141.72% | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
4
Average EPS beat (4)
133.89%
Max EPS beat (4)
504.52%
Min EPS beat (4)
4.88%
Revenue beat statistics
Revenue beat (4)
2
Average Revenue beat (4)
57.59%
Max Revenue beat (4)
232.24%
Min Revenue beat (4)
-20.11%
Analysis
In the last 4 quarters, PTGX has consistently beaten EPS estimates in all releases
PTGX has beaten revenue estimates in 2 out of the last 4 releases
In the last 4 quarters, PTGX has beaten the EPS estimates by 133.9% on average.
In the last 4 quarters, PTGX has beaten the revenue estimates by 57.6% on average.
PROTAGONIST THERAPEUTICS INC / PTGX Earnings FAQ
Can you provide the last earnings date for PROTAGONIST THERAPEUTICS INC?
PROTAGONIST THERAPEUTICS INC (PTGX) last reported earnings on 2/19/2026.
Did PTGX stock beat earnings estimates in the most recent quarter?
PROTAGONIST THERAPEUTICS INC (PTGX) beat EPS estimates and beat revenue estimates in the most recent quarter.
How often does PROTAGONIST THERAPEUTICS INC (PTGX) beat earnings estimates?
In the last 4 quarters, PROTAGONIST THERAPEUTICS INC (PTGX) has beaten EPS estimates in 4 out of 4 releases.